Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sergey A. Katorkin"'
Autor:
Ksenia A. Mima, Elena I. Katorkina, Sergey A. Katorkin, Sodnom Zh. Tsybanov, Aleksandr S. Malogolovkin
Publikováno v:
Вопросы вирусологии, Vol 65, Iss 2, Pp 103-112 (2020)
Introduction. African swine fever virus (ASF) is a large DNA virus that is the only member of the Asfarviridae family. The spread of the ASF virus in the territory of the Russian Federation, Eastern Europe and China indicates the ineffectiveness of e
Externí odkaz:
https://doaj.org/article/c2666db6d5714bff897ccc6f29e57907
Autor:
Mariya V. Nefedeva, Ilya A. Titov, Sergey A. Katorkin, Sodnom Zh. Tsybanov, Valentina M. Lyska, Alexey D. Sereda, Alexander S. Malogolovkin
Publikováno v:
Medical academic journal. 2:221-228
BACKGROUND: A variety of antibodies against the SARS-CoV-2 with different functional activities can lead to immune pathology and/or modulation of infection due to antibody-dependent enhancement. An important role in the development of ADE, as exempli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b01b795a29e576b8adca01dd7d53f65b
https://doi.org/10.17816/maj108729
https://doi.org/10.17816/maj108729
Autor:
Sodnom Zh. Tsybanov, Sergey A. Katorkin, Elena I. Katorkina, Ksenia A. Mima, Aleksandr S. Malogolovkin
Publikováno v:
Problems of Virology. 65:103-112
Introduction. African swine fever virus (ASF) is a large DNA virus that is the only member of the Asfarviridae family. The spread of the ASF virus in the territory of the Russian Federation, Eastern Europe and China indicates the ineffectiveness of e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8320d527bcd8950ab4e6c0fece24669e
https://doi.org/10.36233/0507-4088-2020-65-2-103-112
https://doi.org/10.36233/0507-4088-2020-65-2-103-112
Autor:
Andrey V, Chupin, Sergey E, Katorkin, Ivan I, Katelnitsky, Oksana V, Katelnitskaya, Igor I, Prostov, Alexey S, Petrikov, Alexander P, Koshevoi, Larisa F, Lyudkova
Publikováno v:
Advances in therapy. 37(5)
Pharmacotherapy is a mainstay of treatment for lower limb chronic venous disease (CVD) and its complications. However, therapeutic agents with evidence-based efficacy for the treatment of CVD are limited. Sulodexide (registered as Vessel Due F in Rus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f895b98af3bb79a19a1215fc8f21f25d
https://pubmed.ncbi.nlm.nih.gov/32862366
https://pubmed.ncbi.nlm.nih.gov/32862366